ImmuCell Corp. (ICCC)
5.84
-0.27
(-4.42%)
USD |
NASDAQ |
Feb 03, 16:00
5.85
+0.01
(+0.17%)
After-Hours: 20:00
ImmuCell Total Liabilities (Quarterly) : 15.93M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 29.94B |
| Cumberland Pharmaceuticals, Inc. | 40.10M |
| AbbVie, Inc. | 136.50B |
| Precipio, Inc. | 7.404M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.73M |
| Shareholders Equity (Quarterly) | 29.80M |
| Debt to Equity Ratio | 0.4566 |
| Current Ratio | 4.208 |
| Net Debt Paydown Yield | 0.79% |